The 2017 BIO International Convention has partnered with the National Institutes of Health (NIH) and the National Science Foundation (NSF) to feature Small Business Innovation Research (SBIR) funded early-stage biotech companies in the BIO Innovation Zone. The SBIR program provides U.S. federal funding to small businesses engaged in Research/R&D with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process prior to receiving the funding.
The majority of participating companies in the BIO Innovation Zone have received SBIR Phase II grant/s, which provide up to $1 million dollars or more in funding to engage in R&D that has the potential for commercialization.
The Innovation Zone companies, focused on drug discovery, diagnostics and other platform technologies, will have dedicated exhibit space and the ability to participate in BIO’s One-on-One Partnering™ system. Visit the Innovation Zone in the BIO Exhibition to meet the 70+ SBIR grantees supported by the National Institutes of Health and the National Science Foundation. Select companies featured in the Zone will tell their story in a special track of company presentations.
If you are interested in exhibiting in the Innovation Zone, please contact Melissa Arndorfer at email@example.com.